$0.00
0.00%
Nasdaq, Nov 22, 03:30 pm CET
ISIN
US8091711015
Symbol
SCPS
Sector
Industry

Scopus Biopharma Inc Stock price

$0.00
-0.00 83.33% 1M
-0.00 85.71% 6M
-0.04 99.30% YTD
-0.06 99.49% 1Y
-2.80 99.99% 3Y
-5.92 99.99% 5Y
-5.92 99.99% 10Y
Nasdaq, Closing price Mon, Nov 25 2024
+0.00 0.00%
ISIN
US8091711015
Symbol
SCPS
Sector
Industry

Key metrics

Market capitalization $10.00k
Enterprise Value $-1.40m
EV/FCF (TTM) EV/FCF 0.46
Revenue (TTM) Revenue $0.00
EBIT (operating result TTM) EBIT $-9.34m
Free Cash Flow (TTM) Free Cash Flow $-3.04m
Cash position $360.00k
EPS (TTM) EPS $-0.32
Short interest 0.25%

Is Scopus Biopharma Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Scopus Biopharma Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast Scopus Biopharma Inc:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast Scopus Biopharma Inc:

Buy
100%

Financial data from Scopus Biopharma Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '23
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 4.08 4.08
75% 75%
-
- Research and Development Expense 5.27 5.27
328% 328%
-
-9.34 -9.34
46% 46%
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT -9.34 -9.34
46% 46%
-
Net Profit -8.70 -8.70
45% 45%
-

In millions USD.

Don't miss a Thing! We will send you all news about Scopus Biopharma Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Scopus Biopharma, Inc. is a biopharmaceutical company, which engages in the development of transformational therapeutics targeting serious diseases with unmet medical needs. Its drug candidates comprises of combination of cannabidiol-mediated, opioid-sparing anesthetics, synthesis of cannabinoids, and cannabinoid receptor mediating compounds for the treatment of systemic sclerosis. The company was founded on April 18, 2017 and is headquartered in New York, NY.

Head office United States
CEO Morris Laster
Founded 2017
Website www.scopusbiopharma.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today